[go: up one dir, main page]

DK3368046T3 - Synthetic composition and method for modulating brain function and behaviour - Google Patents

Synthetic composition and method for modulating brain function and behaviour Download PDF

Info

Publication number
DK3368046T3
DK3368046T3 DK16859111.3T DK16859111T DK3368046T3 DK 3368046 T3 DK3368046 T3 DK 3368046T3 DK 16859111 T DK16859111 T DK 16859111T DK 3368046 T3 DK3368046 T3 DK 3368046T3
Authority
DK
Denmark
Prior art keywords
behavior
brain function
synthetic composition
modulating brain
modulating
Prior art date
Application number
DK16859111.3T
Other languages
English (en)
Inventor
Emma Elison
Bruce Mcconnell
Louise Kristine Vigsnæs
Original Assignee
Glycom As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycom As filed Critical Glycom As
Application granted granted Critical
Publication of DK3368046T3 publication Critical patent/DK3368046T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK16859111.3T 2015-10-28 2016-10-28 Synthetic composition and method for modulating brain function and behaviour DK3368046T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201570696 2015-10-28
DKPA201670100 2016-02-24
PCT/DK2016/050344 WO2017071715A1 (en) 2015-10-28 2016-10-28 Synthetic composition and method for modulating brain function and behaviour

Publications (1)

Publication Number Publication Date
DK3368046T3 true DK3368046T3 (da) 2022-10-31

Family

ID=58629784

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16859111.3T DK3368046T3 (da) 2015-10-28 2016-10-28 Synthetic composition and method for modulating brain function and behaviour

Country Status (7)

Country Link
US (2) US10835545B2 (da)
EP (1) EP3368046B1 (da)
CN (1) CN108348535B (da)
DK (1) DK3368046T3 (da)
ES (1) ES2927009T3 (da)
PL (1) PL3368046T3 (da)
WO (1) WO2017071715A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3452051T3 (en) * 2016-05-05 2022-09-05 Glycom As COMPOSITION COMPRISING HMOs FOR USE IN THE TREATMENT OF MAST CELL MEDIATED VISCERAL HYPERSENSITIVITY AND/OR PAIN
WO2017198276A1 (en) * 2016-05-19 2017-11-23 Glycom A/S Synthetic composition
EP3634429A4 (en) * 2017-05-09 2020-11-04 Glycom A/S SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
EP3630123A4 (en) * 2017-05-24 2020-10-28 Glycom A/S SYNTHETIC COMPOSITION CONSISTING OF ONE OR MORE HUMAN MILK OLIGOSACCHARIDES (HMOS)
US11541069B2 (en) 2017-11-02 2023-01-03 Glycom A/S One or more HMOs for reducing or preventing fatigue and/or improving focus or concentration
KR20190130720A (ko) * 2018-05-15 2019-11-25 (주)에이피테크놀로지 2'-푸코실락토오스를 포함하는 뇌졸중 예방용 조성물
CN113226506B (zh) * 2018-12-19 2023-05-12 格礼卡姆股份公司 寡糖的分离
JP2023503541A (ja) * 2019-11-27 2023-01-31 グリコム・アクティーゼルスカブ Ｈｍｏの混合物
EP4072319A1 (en) * 2019-12-11 2022-10-19 Société des Produits Nestlé S.A. Compositions for use in the reduction of nociception and other health benefits in infants and young children
CN114828646A (zh) * 2019-12-19 2022-07-29 希尔氏宠物营养品公司 治疗和降低与升高的4-乙基苯基硫酸盐相关的病状风险的组合物和方法
MX2023006135A (es) * 2020-12-04 2023-06-06 Glycom As Oligosacaridos de leche humana para uso en el apoyo a la maduracion o la mejora de los patrones de sue?o.
WO2023237305A1 (en) 2022-06-09 2023-12-14 Société des Produits Nestlé S.A. Nutritional composition comprising gos and hmos

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
CA2645141C (en) 2006-03-09 2018-07-10 Centre National De La Recherche Scientifique (Cnrs) Method of producing sialylated oligosaccharides
WO2010115934A1 (en) 2009-04-07 2010-10-14 Glycom A/S Synthesis of 2'-o-fucosyllactose
EP2451462B1 (en) * 2009-07-06 2017-09-06 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
DK2289527T3 (da) * 2009-08-25 2018-04-23 Nestec Sa Bifidobacterium longum og funktionelle gi-sygdomme
EP2536737B1 (en) 2010-02-19 2017-05-31 Glycom A/S A method for preparation of the tetrasaccharide lacto-n-neotetraose (lnnt) containing n-acetyllactosamine
CA2805499A1 (en) 2010-07-16 2012-01-19 Glycom A/S Derivatization of oligosaccharides
MX2013007736A (es) 2010-12-29 2013-07-24 Nestec Sa Una composicion nutricional que comprende fibra y probioticos para reducir sintomas intestinales relacionados con estres.
SG191393A1 (en) 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
BR112013020108A2 (pt) 2011-02-10 2017-06-13 Nestec Sa modulação do crescimento de bifidobactérias usando uma combinação de oligossacarídeos encontrados no leite de ser humano
WO2012113404A1 (en) 2011-02-21 2012-08-30 Glycom A/S Novel glycosyl phosphites
CN103443113A (zh) 2011-03-18 2013-12-11 格力康公司 新型含岩藻糖的糖类衍生物的合成
CN103703012A (zh) 2011-05-13 2014-04-02 格礼卡姆股份公司 乳糖-n-四糖的制造
JP2014513985A (ja) 2011-05-13 2014-06-19 グリコム アー／エス 人乳オリゴ糖（ｈｍｏ）又はその前駆体の形成方法
BR112013029203A2 (pt) 2011-05-13 2016-08-09 Glycom As método para a preparação de um ou mais oligossacarídeos de leite humano, e, uso de oligossacarídeos de leite humano
CN104023560A (zh) * 2011-08-29 2014-09-03 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
WO2013044928A1 (en) 2011-09-30 2013-04-04 Glycom A/S Synthesis of hmo core structures
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
WO2013139344A1 (en) 2012-03-20 2013-09-26 Glycom A/S Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
MX2014012362A (es) * 2012-04-13 2015-05-07 Trustees Boston College Composición prebiótica y métodos de uso.
EP2842560A4 (en) 2012-04-23 2015-12-02 Univ Kyoto COMPOSITION TO PROMOTE THE GROWTH OF BIFIDOBAKTERIA
ES2572831T3 (es) 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
DK2708147T3 (da) 2012-09-14 2020-05-18 Abbott Lab Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose
EP2934189B1 (en) * 2012-12-18 2019-11-06 Abbott Laboratories Human milk oligosaccharides to ameliorate symptoms of stress
CN104955344A (zh) 2012-12-18 2015-09-30 雅培制药有限公司 包含神经保护膳食寡糖的营养组合物
BR112015022820A8 (pt) 2013-03-12 2019-11-26 Nestec Sa ensaio para selecionar um regime de tratamento para um indivíduo com depressão, uso de um composto compreendendo folato, composição e kit
HK1231398A1 (zh) 2014-04-08 2017-12-22 Abbott Laboratories 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
US20150305384A1 (en) 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
WO2016066175A1 (en) * 2014-10-29 2016-05-06 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
US11040050B2 (en) * 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US11040049B2 (en) * 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US20160243139A1 (en) 2014-10-29 2016-08-25 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US20160287637A1 (en) 2014-12-08 2016-10-06 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
EP3368047B1 (en) * 2015-10-28 2023-04-26 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
WO2017144062A1 (en) * 2016-02-24 2017-08-31 Glycom A/S Synthetic composition for microbiota modulation
WO2017198276A1 (en) * 2016-05-19 2017-11-23 Glycom A/S Synthetic composition
EP3589139A4 (en) * 2017-03-01 2020-12-23 Glycom A/S SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
CN111556755A (zh) * 2017-12-05 2020-08-18 格礼卡姆股份公司 用于治疗偏头痛的人乳寡糖

Also Published As

Publication number Publication date
CN108348535B (zh) 2021-08-31
ES2927009T3 (es) 2022-10-31
US20180369260A1 (en) 2018-12-27
US11684630B2 (en) 2023-06-27
EP3368046A4 (en) 2019-07-03
CN108348535A (zh) 2018-07-31
PL3368046T3 (pl) 2022-11-28
US20210077513A1 (en) 2021-03-18
WO2017071715A1 (en) 2017-05-04
EP3368046A1 (en) 2018-09-05
EP3368046B1 (en) 2022-07-27
US10835545B2 (en) 2020-11-17

Similar Documents

Publication Publication Date Title
IL286669A (en) Compounds and methods for modulating tmprss6 expression
DK3368046T3 (da) Synthetic composition and method for modulating brain function and behaviour
IL285229A (en) Compounds and methods for modulating RNA function
IL258486B (en) Compounds, compositions, and methods for modulating cftr
ZA201801600B (en) Compounds and methods for modulating angiotensinogen expression
IL252573A0 (en) Systems and methods for modulating nerves or other tissue
IL289789A (en) Compounds and methods for reducing tau expression
GB201512283D0 (en) Track behaviour events
EP3183346C0 (en) CHANNEL MODULATORS
MA53943A (fr) Modulateurs de ror-gamma
EP4141374C0 (en) DRUM CHARGER ASSEMBLY AND METHODS
EP3369091C0 (en) SYSTEMS AND METHODS FOR CONTROLLING VERGENT EYE MOVEMENTS
EP3151792C0 (en) SYSTEM AND METHOD FOR SENSOR-DRIVEN SMART ORAL APPLIANCE
EP3466435C0 (en) BRAIN FUNCTION IMPROVING AGENT
IL241439B (en) Preparations and methods for modulating tau expression
EP3333833A4 (en) TECHNOLOGY SIMULATOR
PT3353303T (pt) Composições e métodos para modulação da expressão de ataxina 3
FI20155621A7 (fi) Menetelmä ja tuote
ZA201706673B (en) Modified bituminous binder emulsion
DK3283041T3 (da) Collagenstimuleringsanordning
HUE055445T2 (hu) Mikrokapszula szuszpenzió
DE112015004631A5 (de) Laserbauelement und Verfahren zu seiner Herstellung
EP3467078A4 (en) ODOR MODULATION AGENT AND ODOR MODULATION METHOD
EP3349748A4 (en) COMPOSITION AND METHOD THEREFOR
GB201611699D0 (en) Behaviour modification